Medical News


Research and Markets announces the addition of this 2004 Vendor Analysis on IBA Health to its offerings.

January 14 2004–IBA Health has had a mixed year. It has shown a profit this year and thought it had made a significant deal in the UK market for distributing its products. This has become un-stuck with the iSoft/Torex merger plan but IBA has solidified its position in Asia and in its home markets.

The company needs to rapidly attract the right partners globally and create a much stronger ecosystem. It claims to be more focused on the Asian markets but needs to be a player globally. The company also needs to continue its focus on earnings this year and continue with its acquisition program.

For a complete index of this report click on http://www.researchandmarkets.com/reports/42645

About Research and Markets Ltd.
Research and Markets Ltd. are Europe’s largest resource for market research. R&M distribute thousands of major research publications from the world’s leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists



Related Articles
  • Projected value of UK private healthcare market at ?16.18bn in 2003
  • Worldwide prevalence of psoriasis estimated at nearly 14 million people in 2004
  • Insufficent time dedicated to diagnosis and treatment of migraine.
  • Increased need for Market Intelligence in the Competitive World Medical Device Market.
  • Value of worldwide market for therapeutic vaccines estimated to reach approximately $2.1B by 2009
  • No comments yet. Be the first.

    Leave a reply

    Research and Markets announces the addition of this 2004 Vendor Analysis on IBA Health to its offerings.

    January 14 2004–IBA Health has had a mixed year. It has shown a profit this year and thought it had made a significant deal in the UK market for distributing its products. This has become un-stuck with the iSoft/Torex merger plan but IBA has solidified its position in Asia and in its home markets.

    The company needs to rapidly attract the right partners globally and create a much stronger ecosystem. It claims to be more focused on the Asian markets but needs to be a player globally. The company also needs to continue its focus on earnings this year and continue with its acquisition program.

    For a complete index of this report click on http://www.researchandmarkets.com/reports/42645

    About Research and Markets Ltd.
    Research and Markets Ltd. are Europe’s largest resource for market research. R&M distribute thousands of major research publications from the world’s leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

    For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com

    Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
    • Digg
    • del.icio.us
    • Netvouz
    • DZone
    • ThisNext
    • MisterWong
    • Wists



    Related Articles
  • Projected value of UK private healthcare market at ?16.18bn in 2003
  • Worldwide prevalence of psoriasis estimated at nearly 14 million people in 2004
  • Insufficent time dedicated to diagnosis and treatment of migraine.
  • Increased need for Market Intelligence in the Competitive World Medical Device Market.
  • Value of worldwide market for therapeutic vaccines estimated to reach approximately $2.1B by 2009
  • No comments yet. Be the first.

    Leave a reply